活体供者子宫移植后每活产成本:瑞典活体供者试验结果
该研究基于瑞典一项纳入9例活体供者子宫移植的前瞻性队列,从医疗保健角度计算每活产成本。9例移植中7例手术成功,6例女性共分娩9名儿童;每名儿童总成本为124894欧元,仅计手术成功移植时为107120欧元。局限性包括样本量有限、技术处于实验阶段及结果仅反映瑞典一国成本。
要点
- 每名儿童总成本为124894欧元;仅计手术成功移植(9例中7例)时每活产成本为107120欧元。
- 术前准备联合体外受精、手术及术后2个月随访成本约占总成本的53%。
- 监测、胚胎移植联合额外体外受精、免疫抑制及其他药物、妊娠护理与分娩及新生儿护理各占较小部分。
核心结论
- 从医疗保健角度,每名儿童总成本计算为124894欧元;若仅考虑手术成功的移植(9例中7例),每活产总成本为107120欧元。
- 未来每名儿童成本很可能因预测的手术成功率增加、手术时间缩短、移植物维持至活产的时间缩短以及移植后获得两或三个单胎的比率增加而下降。
研究设计与样本
- 该真实数据卫生经济学成本研究基于一项前瞻性队列研究,纳入9例活体供者子宫移植手术。
- 研究时长包括从首次移植前检查至移植物切除后术后对照的时间。
- 参与者包括9例子宫移植手术的受者、活体供者及新生儿。
主要发现
- 9例移植手术中7例手术成功(血供充足且月经规律),6例女性共分娩9名儿童。
- 每名儿童总成本计算为124894欧元;若仅考虑手术成功的移植(9例中7例),每活产成本为107120欧元。
- 术前准备联合体外受精、手术及术后2个月随访成本约占总成本的53%。
- 监测、胚胎移植联合额外体外受精成本占14%,从第3个月至子宫切除的免疫抑制及其他药物成本占13%,妊娠护理联合分娩及新生儿护理成本占13%。
局限性
- 局限性为样本量有限、该操作处于实验阶段,且结果仅反映一国(瑞典)的成本。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: What is the cost per live birth after live donor uterus transplantation in a Swedish clinical trial setting? SUMMARY ANSWER: The total cost per child, from a health care perspective, was calculated to be €124 894 and if only surgically successful transplants are considered, the total cost per live birth was €107 120. WHAT IS KNOWN ALREADY: Uterus transplantation has proved to be a feasible treatment for uterine factor infertility by accomplished live births, both after live donor and deceased donor transplantation procedures. Our previous study, the only existing cost analysis of uterus transplantation, found that the initial (up to 2 months after surgeries) societal costs of preoperative interventions, live donor uterus transplantation surgeries, and postoperative care were between €50 000 and €100 000 (mean €74 000) in Year 2020 values per uterus transplantation. That study also included costs of sick leave for both donors and recipients. STUDY DESIGN, SIZE, DURATION: This real-data health economic cost study is based on a prospective cohort study, which included nine live donor uterus transplantation procedures. Study duration included the time from the first pre-transplantation investigation until postoperative controls after graft removal. PARTICIPANTS/MATERIALS, SETTING, METHODS: Recipients, live donors, and neonates of nine uterus transplantation procedures participated. The recipients and donors underwent pre-transplantation investigations with imaging, laboratory tests, and psychological/medical screening. In vitro fertilization with embryo cryopreservation was performed in advance of transplantation. Donor hysterectomy and transplantation were by laparotomy and the recipient received immunosuppression. Pregnancy attempts by ET started 1 year after transplantation and delivery was by caesarean section. Hysterectomy was performed either after birth of one or two children, after graft failure, or after multiple pregnancy failures. Nine transplantation procedures resulted in seven surgically successful (adequate blood flow and regular menstruations) grafts and six women delivered a total of nine children. MAIN RESULTS AND THE ROLE OF CHANCE: The total cost of preoperative investigations, live donor uterus transplantation, postoperative care, immunosuppression, IVF, follow-up, pregnancy care, delivery, and graft removal after completed childbirth(s) or failure to achieve live birth was calculated, based on inclusion of cost for six women, giving birth to a total of nine children, and three women, with no childbirth. Cost for live donors was also included in the analysis. The total cost per child was calculated to be €124 894. However, if only surgical successful transplants (seven out of nine transplants) are considered, the cost per live birth was €107 120. The cost for preoperative preparations with IVF, surgeries, and postoperative follow-up during the initial 2 months was around 53% of total costs. Smaller sub-costs were those for monitoring, ETs with additional IVF (14%), immunosuppression and other drugs from Month 3 until hysterectomy (13%), and pregnancy care with delivery and neonatal care (13%). LIMITATIONS, REASONS FOR CAUTION: Limitations are the restricted sample size, the experimental phase of the procedure and that the results only reflect the cost in one country (Sweden). WIDER IMPLICATIONS OF THE FINDINGS: The results provide the first information concerning the cost per child of the uterus transplantation intervention. In the future, the cost per child will most likely decrease due to predicted increase in the rate of surgical success, decreased surgical durations, decreased graft duration to achieve live birth(s), and increased rate of transplantations giving not only one, but two or three singletons. STUDY FUNDING/COMPETING INTEREST(S): Funding was received from the Jane and Dan Olsson Foundation for Science, the Knut and Alice Wallenberg Foundation, the Swedish Research Council, and an ALF grant from the Swedish state under an agreement between the government and the county councils. There are no conflicts of interest for any of the authors. TRIAL REGISTRATION NUMBER: NCT01844362.
引用
- Brännström M, Ekberg J, Sandman L, et al. The costs per live birth after uterus transplantation: results of the Swedish live donor trial. Hum Reprod. 2025. PMID: 39675045. doi:10.1093/humrep/deae272
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。